Metastatic Colorectal Cancers Completed Phase 3 Trials for Oxaliplatin (DB00526)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

DBCOND0063579 (Metastatic Colorectal Cancers)Completed3 IdentifierTitlePurposeDrugs
NCT00252564Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerTreatment
NCT01228734A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsTreatment
NCT00145314FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerTreatment
NCT00399035Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerTreatment
NCT01030042Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsTreatment
NCT01219920FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal CancerTreatment